Sonelokimab Antibody
Sonelokimab (ALX 0761) is a trivalent nanobody therapeutic candidate that simultaneously inhibits the pro-inflammatory cytokines IL-17A and IL-17F. It is being investigated for the treatment of plaque psoriasis, with research encompassing both in vitro mechanistic studies and in vivo preclinical models of autoimmune disease.
Product Specifications
Target
MMP, Interleukin
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Protein Biochemistry
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15128322 1 Vial
Lentiviral human WRAP53 shRNA (UAS) - Lentiviral human WRAP53 shRNA (UAS) (100)
Sign In for Pricing
View Details 
KLR2333 96 Well
Rat β-site APP-Cleaving Enzyme 1, BACE1 GENLISA ELISA
Sign In for Pricing
View Details